Background: The infection of HCV is recognized worldwide as an important community health problem. There is an optimistic correlation between accumulation of iron in hepatocytes and amplified serum levels of markers, counting ferritin and transferrin. Aim: The goal of this study is to determine the response of serum levels of ferritin after the patient’s treatment with HCV infection. Material and methods: The study included 140 HCV-infected patients. All subjects were evaluated for clinical topographies, including HCV viral load, status of serum iron levels and biochemical data. The obtained outcomes were calculated by means of Microsoft Excel 2013. Results: The results showed that treatment with antiviral drugs interfered significantly the iron deposition in hepatocytes and have association between iron accumulation and HCV treatment. The mean iron value was 20.02 µmol / L for the positive PCR patients; and for a negative PCR reaction, 25.11 µmol / L was the estimated value before treatment. Both values were lower the normal array of 9-31.3 µmol / L. It is estimated that the mean ferritin value for negative PCR (668.55 µmol / L) and positive PCR (913.14 µmol / L) is above normal range which is 221 to 641.35 µmol / L. Conclusions: Patients with chronic HCV are significantly related to serum iron levels. High levels of iron and ferritin were associated significantly with the disease, resulting progressive fibrosis in the liver. There is no considerable change in serum iron markers among subjects with increased or less severity of HCV infection. The severity of the disease can be evaluated easily by measuring the serum transferrin levels along with ferritin levels, which are linked with the progression of fibrosis of the liver and necro-inflammatory activity. Keywords: levels of serum ferritin; iron load; drug; liver cells and HCV infection.
PLA (Pyogenic Liver Abscess) is a fatal disease. It is quite difficult to diagnose this disease at the early stages. Huge changes were observed in the epidemiology and mortality of this disease in past years. For a more efficient diagnosis of this illness, there is a need to understand the pathological cycle of this disease. Objective: Due to the lack of diagnostic methods for early detection of PLA (Pyogenic Liver Abscess), it is impossible to treat and control this illness; there is a need to understand the pathogenicity of the disease to find the most appropriate way of detection. To find a suitable detection method is necessary for the further treatment and eradication of the disease. Study Design: It is a retrospective study with statistical approach, conducted in Medicine of Department of M. Islam Medical and Dental College Gujranwala for six months duration from July 2021 to December 2021. Methods: To find an appropriate diagnostic method for the detection of Pyogenic liver abscess, samples of 118 patients were selected. The clinical data related to pathogenicity, symptoms of illness, demographic distribution, treatment history, and the mortality rate was carefully noted, Patients were non-amoebic illnesses were selected for this study. Leukocytes and C-reactive protein values of the patients were also estimated. Microbes involved in this disease were also identified Results: The microbe involved in PLA was Klebsiella pneumonia. This disease was more prevalent in males in the age group 57 years. In more severe patients WBCs level was significantly high and CRP values were also aroused much. 67 % of patients have a high level of leukocytes. The mortality rate was about 6 % in these patients. Conclusion: After complete demographic, clinical, C-reactive protein level, evaluation of leukocytes, imaging results by ultrasound might help to diagnose this disease at an early stage. For the treatment of illness, image guided catheter and proper usage of antibiotics is recommended. Keywords: Pyogenic Liver Abscess, Biliary Pathology, Diagnosis of PLA, concomitant disease, catheter drainage
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.